- Sirolimus, also
known as
rapamycin and sold
under the
brand name
Rapamune among others, is a
macrolide compound that is used to coat
coronary stents, prevent...
- drug
Rapamune.
Wyeth is
targeted in the suit for off-label marketing,
targeting specific doctors and
medical facilities to
increased sales of
Rapamune, trying...
-
marketed sirolimus (
Rapamune) for off-label uses,
targeted specific doctors and
medical facilities to
increase sales of
Rapamune,
tried to get transplant...
- unchanged.
Quetiapine (Seroquel)
Repaglinide (Prandin)
Sirolimus (Rapamycin,
Rapamune)
Tamoxifen (Nolvadex):
Tamoxifen is
metabolized by CYP2D6 into its active...
- and has less
pronounced side-effects.
Sirolimus (rapamycin,
trade name
Rapamune) is a
macrolide lactone,
produced by the
actinomycete bacterium Streptomyces...
-
Ranivisio Raniviz ranolazine (INN)
ranpirnase (INN)
rapacuronium bromide (INN)
Rapamune Rapiblyk Raplon rasagiline (INN, USAN)
rasburicase (INN)
raseglurant (INN)...
-
immunosuppressant drug
Rapamune. The
government alleged that
Wyeth violated the
False Claims Act, from 1998
through 2009, by
promoting Rapamune for unapproved...
-
treat metastatic pancreatic cancer, was
approved by FDA in
October 2015.
Rapamune is a nanocrystal-based drug that was
approved by the FDA in 2000 to prevent...
-
Justice against Pfizer Pharmaceutical involving the kidney-transplant drug
Rapamune. On July 30, 2013, The U.S.
Department of
Justice announced that Pfizer...
-
criminal and
civil liability arising from the
unlawful marketing of its drug
Rapamune for uses that were not FDA-approved and
potentially harmful. In 2014, CareFusion...
